Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves subcutaneous Actemra for active polyarticular juvenile idiopathic arthritis

May 15, 2018

Zymeworks and Daiichi Sankyo expand immuno-oncology collaboration

May 15, 2018

Medisix Therapeutics closes series A financing

May 15, 2018

Researchers develop PXDN-mutant microphthalmia and dysgenesis murine model

May 15, 2018

FDA accepts for review BLA for pegfilgrastim biosimilar CHS-1701

May 15, 2018

Soleno Therapeutics initiates phase III study of DCCR in Prader-Willi syndrome

May 15, 2018

Lymph-directed compound ST-182 simultaneously inhibits MAPK, PI3K and mTOR

May 15, 2018

Galectin proceeds with plans for phase III program with GR-MD-02 in NASH cirrhosis

May 15, 2018

New ELMO3 gene mutation tied to keratoconus

May 15, 2018

Researchers at Ben-Gurion University develop a novel molecule for the treatment of cancer

May 15, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...